You are being forwarded to your requested URL of https://www.lifesciencesipblog.com/orphan-drug-exclusivity-ode-fda-continues-its-attack-2?utm_source=mondaq&utm_medium=syndication&utm_content=sourceoriginal&utm_campaign=